ISU304/CB2679d

· ISU Abxis Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISU304/CB2679d, covering 2020-11-10 to 2020-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients [Phase 1]